Vaxil Bio Ltd experienced a notable decline this week, reflecting broader market trends in the health care sector.
This week, Vaxil Bio Ltd (VXL.V) saw its stock price drop by 9.38%, closing at C$0.14. This decline comes amid a lack of significant news from the company, suggesting that broader market dynamics may be influencing investor sentiment in the health care sector.
Advertisement
Vaxil Bio Ltd
VXL.V
VXL.V
Vaxil Bio Ltd
WealthAwesomeMarket cap
$577,682
P/E
1.0x
52W high
$0.29
52W low
$0.13
1W change
-9.38%
Beta
-0.87
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on VXL's historical volatility
30-Day Vol
75.6%
Annualized
90-Day Vol
108.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.12
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.14 | C$0.11 – C$0.18 |
| 60 trading days | C$0.13 | C$0.09 – C$0.19 |
| 90 trading days | C$0.12 | C$0.08 – C$0.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: With Vaxil Bio Ltd's stock price currently sitting at the lower end of its 52-week range, investors may want to consider both the technical indicators and the company's fundamentals before making decisions.
Vaxil Bio Ltd's Stock Declines 9.38% This Week
The stock's performance reflects broader challenges in the health care sector, with the latest volume significantly below its 20-day average.
Bull case
Vaxil Bio Ltd has a strong return on equity (ROE) of 39.9%, which shows efficient management of equity and the potential for future growth.
Bear case
The stock is currently trading below its 50-day and 200-day moving averages, which could signal continued downward pressure unless a catalyst emerges.
Weekly Price Action
Advertisement
This week, Vaxil Bio Ltd (VXL.V) saw its stock price decline by 9.38%, closing at C$0.14. The stock has not only dropped this week but has also mirrored this performance over the past month, with a consistent decline of 9.38%. Year-to-date, the stock remains unchanged, suggesting a period of stagnation amidst varying market conditions.
Technical Picture
From a technical standpoint, Vaxil Bio Ltd is currently trading below both its 50-day moving average of C$0.16 and its 200-day moving average of C$0.17, indicating potential bearish sentiment. The stock's 52-week range has been between C$0.13 and C$0.29, with the current price sitting at approximately 9% of this range. The beta of -0.87 suggests that Vaxil's stock is less volatile than the market, which may appeal to risk-averse investors. Notably, the latest trading volume of 500 shares is significantly lower than the 20-day average volume of 4,541 shares, reflecting reduced trading activity.
Insider Activity
There have been no reported insider transactions for Vaxil Bio Ltd in recent weeks, which may indicate a wait-and-see approach from those closely involved with the company.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
